|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$84,286,221 |
|
|
Indirect Value
|
$13,081,599,865 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,165,886,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 46 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$13,950,186 |
I/I |
(1,599,792) |
3,474,819 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$170,572 |
I/I |
(19,561) |
75,598 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
80,000 |
106,933 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
925,000 |
5,074,611 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,916,150 |
5,390,969 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
466,050 |
471,007 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
316,500 |
320,498 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,101,300 |
3,254,517 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$5,040,423 |
I/I |
560,047 |
3,814,564 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$42,723 |
I/I |
4,747 |
475,754 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$556,848 |
I/I |
61,872 |
137,470 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$17,400,807 |
I/I |
1,933,423 |
7,326,145 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$359,199 |
I/I |
39,911 |
360,409 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$1,404 |
I/I |
160 |
475,914 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$18,292 |
I/I |
2,084 |
139,554 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$571,758 |
I/I |
65,139 |
7,391,284 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$11,797 |
I/I |
1,344 |
361,753 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$165,623 |
I/I |
18,869 |
3,833,433 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$864,105 |
I/I |
95,716 |
7,487,000 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$17,288 |
I/I |
1,915 |
363,668 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$2,338 |
I/I |
259 |
476,173 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$27,490 |
I/I |
3,045 |
142,599 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$7,371 |
I/I |
819 |
143,418 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$873 |
I/I |
97 |
363,765 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$231,681 |
I/I |
25,744 |
7,512,744 |
2.25 |
- |
|
1397 Records found
|
|
Page 46 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|